Prospective Study of Outcomes in Adults with Nonalcoholic Fatty Liver Disease

20211,019 citationsJournal Articlebronze Open Access

Authors

Arun J. Sanyal · Virginia Commonwealth University

Mark L. Van Natta · Johns Hopkins University

Jeanne M. Clark · Johns Hopkins University

Brent A. Neuschwander‐Tetri · Saint Louis University

Anna‐Mae Diehl · Duke University

Srinivasan Dasarathy · Cleveland Clinic

Rohit Loomba ·

Abstract

In this prospective study involving patients with NAFLD, fibrosis stages F3 and F4 were associated with increased risks of liver-related complications and death. (Funded by the National Institute of Diabetes and Digestive and Kidney Diseases and others; NAFLD DB2 ClinicalTrials.gov number, NCT01030484.).

Topics & Keywords

Liver Disease Diagnosis and Treatment Liver Disease and Transplantation Diet, Metabolism, and Disease

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: New England Journal of Medicine

Volume 385, Issue 17, pp. 1559-1569

DOI: 10.1056/nejmoa2029349

Field-Weighted Citation Impact: 102.25